1Davis GL.Monitoring of viral levels during therapy of hepatitis C.Hepatology,2002,36:s145-s151.
2McHutcinson J,Davis GL,Esteban-Mur R,et al.Durability of sustained virological response in patients with chronic hepatitis C after treatment with interferon alfa-2b alone or in combination with ribavirin (abstract).Hepatology,2001,34:244A.
3Saracco G,Olivero A,Ciancio A,et al.A randomized 4-arm multi-center Study of interferon alfa -2b plus ribavirivg in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy.Hepatology,2002,36:959-966.
4Di Marco V,Almasio P,Vaccaro A,et al.Combined treatment of relapse of chronic hepatitis C with high-dose α-2b interferon plus ribavirin for 6 to 12 months.J Hepatol,2000,33:456-462.
5Min AD,Jones JL,Esposito S,et al.Efficacy of high-dose interferon in combination with vibavrin in patients with chronic hepatitis C resistant to interferon alone. Am J Gastroenterol,2001,96:1143-1149.
6jacobson IM,Ahmed F,Russo MW,et al.Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C:Artial in prior nonresponders to interferon montherapy or combination therapy and in combination therapy relapsers:final results.Gastroenterology,2003,124:A714.
7Davis GL,Wong JB,McHutchinson JG,et at.Early virologic response to treatment with peginterferon alfa-2b plus ribavrin in patients With chronic hepatitis C. Hepa tolo gy,2003,38:645-652.
8Balnn V,Schwartz D,Wu CY,etal.Erythropoietic response to anemia in chronic hepatitis C Patients receiving combination pegylated interferon/ribavirin.Am Gastroenterol,2005,100:299-307.
9Ahmed F,Jacobson IM. Treatment of relapsers after combination therapy for chronic hepatitis C .Gastroenterol Clin N Am,2004,33:513-526.
